Sumitomo Chemical India achieved record profit after tax of ₹543.14 crore in FY26, up over 7%. Revenue grew 3% to ₹3,156.34 crore. A new Dahej plant nears completion, and the company gains priority for new molecule introductions from its Japanese parent.
Sumitomo Chemical India Posts Record FY26 Performance
Sumitomo Chemical India's profit after tax rose over 7% to ₹543.14 crore in FY 2025-26. Revenue from operations increased 3% to ₹3,156.34 crore.
Reader Takeaway: Record profits driven by margin focus and expansion; watch monsoon impact.
What just happened
Sumitomo Chemical India Limited (SCIL) has announced a record financial performance for the fiscal year 2025-26. Despite facing an challenging environment including erratic monsoons and global trade uncertainties, the company reported a standalone profit after tax of ₹543.14 crore, marking a growth of over 7% compared to the previous fiscal year. Revenue from operations saw a 3% increase, reaching ₹3,156.34 crore.
The company highlighted its focus on maintaining strong margins, achieving an EBITDA margin of 20.7% and a net profit margin of 16.8%.
Why this matters
This record performance demonstrates SCIL's resilience and effective margin management strategies amidst a difficult agrochemical market. The growth, coupled with strategic investments and enhanced global integration, signals potential for sustained future earnings. Key developments include an upcoming manufacturing expansion and improved access to proprietary technologies from its parent company.
The backstory
The company has been working on expanding its manufacturing capabilities. A significant greenfield expansion project at its Dahej plant, with an investment of ₹150 crore, is nearing completion. This is part of a larger strategy to enhance production capacities across multiple sites, including Bhavnagar and Tarapur.
What changes now
SCIL is set to benefit from its elevated status with parent Sumitomo Chemical Company, Japan. India has been placed in the same tier as Japan, Brazil, and North America for early-stage molecule introductions, ensuring better access to advanced global proprietary technology. Furthermore, the company is preparing for an orderly leadership transition, with current Managing Director Mr. Chetan Shah moving to a non-executive role from September 1, 2026, and Dr. Suresh Ramachandran proposed to take over as MD.
Risks to watch
Management has expressed 'cautious optimism' for FY 2026-27. Key risks include potential impacts from a below-normal monsoon forecast, which could affect agricultural input demand. Macro-economic factors like currency depreciation and input price volatility are also being monitored closely. SCIL plans to manage these challenges through product-specific cost adjustments to protect margins.
Peer comparison
While direct peer performance data for FY26 is not provided in the filing, Sumitomo Chemical India operates in the competitive agrochemical sector, facing pressure from both domestic and international players. Its focus on branded formulations, which now constitute 81% of domestic sales, and strong performance in herbicides and metal phosphides, indicate a strategy to build market share through specialized products.
Context metrics (time-bound)
- Revenue from Operations FY 2025-26: ₹3,156.34 crore (up 3%)
- Profit After Tax FY 2025-26: ₹543.14 crore (up over 7%)
- Dahej plant expansion cost: ₹150 crore (nearing commercialization)
- Branded formulations share: 81% of domestic sales
- Herbicides growth: 19% annually
- Metal phosphides growth: 11%
What to track next
Investors will be keen to monitor the successful commissioning of the Dahej manufacturing expansion. The company's ability to navigate the anticipated monsoon challenges and manage input cost volatility will also be crucial. The smooth execution of the leadership transition and the impact of new molecule introductions will be key indicators for future performance.